What's changed? I can think of 30M things that changed...which if you think about is no chump change.
If there's bad news, are they not legally bound to let Pierre know about it before the deal was finalized? Unless it is for some other drug...Which could it be then?
PLX's Fabry drug doing well in the meantime. Pfizer deal means no need to sell equities in the near future. Yet, no amount of good news seems enough to move this stock up. I'm sensing PLX might be planning to do a reverse split and institutions know of the plan and are waiting on the sidelines.
Phase 1 study of LOXO-101 has been accepted for an oral, late-breaking presentation at the AACR-NCI-EORTC Conference on Molecular Targets and Cancer Therapeutics on November 8, 2015 in Boston. Abstracts will be available online on October 26, 2015.
Who knows? She might have lived a month or two longer if she was not treated with antibiotics. Maybe she outlived the other trial patients because she cultivated the Listeria in her system.
Shorting should be banned. Walls Street should be for investing. In a highly advance civilization, I don't see the logic in allowing shorting as a form of investing.
I hope to see the start of recovery in the first week of October just because the 401k source of institutionalized Ponzi scheme monies will start coming in.
Deerfield...I should have known. They are very bad at picking biotechs to invest in and make money mainly from stock manipulation, like what's happening with this stock.
Yes, I've also lost a lot of money on this short. It's hard to fight against big-monied market manipulators. I'm never shorting again. I've learned my painful lesson.
You're also right about 401k money and government pension being thrown into all this. Huge Ponzi scheme.
I thought about adding when it dipped Friday morning but I froze. Bad decision.
What can they buy with 400M clams though? CTIC? It would be nice if they can go after Ariad, but they should have raised 2B instead. Of course, they can always use cash and shares.
Bellicum may be affordable.
Logical, since Gilead acquired YMI and its myelofibrosis drug. Gilead is really itching to expand into onco. I just wish Gild paid double for my YMI shares.